418 related articles for article (PubMed ID: 19152215)
1. Novel genomic methods for drug discovery and mechanism-based toxicological assessment.
Gant TW; Zhang SD; Taylor EL
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):72-80. PubMed ID: 19152215
[TBL] [Abstract][Full Text] [Related]
2. Novel and future applications of microarrays in toxicological research.
Gant TW
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):599-608. PubMed ID: 17696809
[TBL] [Abstract][Full Text] [Related]
3. The promise of toxicogenomics.
Waring JF; Halbert DN
Curr Opin Mol Ther; 2002 Jun; 4(3):229-35. PubMed ID: 12139308
[TBL] [Abstract][Full Text] [Related]
4. Cancer cell-based genomic and small molecule screens.
Caldwell JS
Adv Cancer Res; 2007; 96():145-73. PubMed ID: 17161679
[TBL] [Abstract][Full Text] [Related]
5. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
[TBL] [Abstract][Full Text] [Related]
6. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.
Ganter B; Tugendreich S; Pearson CI; Ayanoglu E; Baumhueter S; Bostian KA; Brady L; Browne LJ; Calvin JT; Day GJ; Breckenridge N; Dunlea S; Eynon BP; Furness LM; Ferng J; Fielden MR; Fujimoto SY; Gong L; Hu C; Idury R; Judo MS; Kolaja KL; Lee MD; McSorley C; Minor JM; Nair RV; Natsoulis G; Nguyen P; Nicholson SM; Pham H; Roter AH; Sun D; Tan S; Thode S; Tolley AM; Vladimirova A; Yang J; Zhou Z; Jarnagin K
J Biotechnol; 2005 Sep; 119(3):219-44. PubMed ID: 16005536
[TBL] [Abstract][Full Text] [Related]
7. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
Lühe A; Suter L; Ruepp S; Singer T; Weiser T; Albertini S
Mutat Res; 2005 Aug; 575(1-2):102-15. PubMed ID: 15924886
[TBL] [Abstract][Full Text] [Related]
8. Exploring functional genomics for drug target and therapeutics discovery in Plasmodia.
Birkholtz L; van Brummelen AC; Clark K; Niemand J; Maréchal E; Llinás M; Louw AI
Acta Trop; 2008 Feb; 105(2):113-23. PubMed ID: 18083131
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomics in predictive toxicology.
Storck T; von Brevern MC; Behrens CK; Scheel J; Bach A
Curr Opin Drug Discov Devel; 2002 Jan; 5(1):90-7. PubMed ID: 11865677
[TBL] [Abstract][Full Text] [Related]
10. Genomics, systems biology and drug development for infectious diseases.
Sakata T; Winzeler EA
Mol Biosyst; 2007 Dec; 3(12):841-8. PubMed ID: 18000561
[TBL] [Abstract][Full Text] [Related]
11. Metabonomics: a platform for studying drug toxicity and gene function.
Nicholson JK; Connelly J; Lindon JC; Holmes E
Nat Rev Drug Discov; 2002 Feb; 1(2):153-61. PubMed ID: 12120097
[TBL] [Abstract][Full Text] [Related]
12. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
13. State-of-the-art genomics approaches in toxicology.
Van Hummelen P; Sasaki J
Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
[TBL] [Abstract][Full Text] [Related]
14. Clustering and its application in multi-target prediction.
Liu W; Johnson DE
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):98-107. PubMed ID: 19152218
[TBL] [Abstract][Full Text] [Related]
15. Drug discovery in reverse.
Smith C
Nature; 2004 Mar; 428(6979):227. PubMed ID: 15014516
[No Abstract] [Full Text] [Related]
16. Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.
Vanderwall DE; Yuen N; Al-Ansari M; Bailey J; Fram D; Green DV; Pickett S; Vitulli G; Luengo JI; Almenoff JS
Drug Discov Today; 2011 Aug; 16(15-16):646-53. PubMed ID: 21601652
[TBL] [Abstract][Full Text] [Related]
17. [DNA microarrays--perspective of application for drug effectivity and safety evaluation].
Roman I
Postepy Biochem; 2008; 54(1):107-15. PubMed ID: 18610588
[TBL] [Abstract][Full Text] [Related]
18. Yeast chemical genomics and drug discovery: an update.
Hoon S; St Onge RP; Giaever G; Nislow C
Trends Pharmacol Sci; 2008 Oct; 29(10):499-504. PubMed ID: 18755517
[TBL] [Abstract][Full Text] [Related]
19. Innovation and greater probability of success in drug discovery and development -- from target to biomarkers.
Kola I; Hazuda D
Curr Opin Biotechnol; 2005 Dec; 16(6):644-6. PubMed ID: 16263257
[No Abstract] [Full Text] [Related]
20. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
Whitebread S; Hamon J; Bojanic D; Urban L
Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
